Cost-Effective Patient Selection for Adjuvant Therapy in Stage IIIA Melanoma

MLA

Vernon K. Sondak, et al. “Cost-Effective Patient Selection for Adjuvant Therapy in Stage IIIA Melanoma.” Journal of the American College of Surgeons, vol. 231, Nov. 2020, pp. 554–56. EBSCOhost, https://doi.org/10.1016/j.jamcollsurg.2020.08.751.

APA

Vernon K. Sondak, Jane L. Messina, & Ahmad A. Tarhini. (2020). Cost-Effective Patient Selection for Adjuvant Therapy in Stage IIIA Melanoma. Journal of the American College of Surgeons, 231, 554–556. https://doi.org/10.1016/j.jamcollsurg.2020.08.751

Chicago

Vernon K. Sondak, Jane L. Messina, and Ahmad A. Tarhini. 2020. “Cost-Effective Patient Selection for Adjuvant Therapy in Stage IIIA Melanoma.” Journal of the American College of Surgeons 231 (November): 554–56. doi:10.1016/j.jamcollsurg.2020.08.751.